{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:06:29Z","timestamp":1788926789003,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03361-z","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T05:14:27Z","timestamp":1787202867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Feasibility and safety of accelerated MVAC (aMVAC) in geriatric patients with muscle-invasive bladder cancer"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6245-9739","authenticated-orcid":false,"given":"Sai","family":"Prasath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6378-7694","authenticated-orcid":false,"given":"Deepak","family":"Sundriyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0796-4502","authenticated-orcid":false,"given":"S P","family":"Harsha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9380-5144","authenticated-orcid":false,"given":"Anusha Mruthyunjaya","family":"Swamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7821-2058","authenticated-orcid":false,"given":"Karthik","family":"Jayalingappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7764-0044","authenticated-orcid":false,"given":"Mayank","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2899-4385","authenticated-orcid":false,"given":"Mahesh","family":"Koulagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6441-6775","authenticated-orcid":false,"given":"Vikas Kumar","family":"Panwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8040-9935","authenticated-orcid":false,"given":"Ankur","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7100-8999","authenticated-orcid":false,"given":"Amit","family":"Sehrawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"3361_CR1","unstructured":"World Health Organization. Ageing [Internet]. Geneva: World Health Organization; [cited 2026 Jun 2]. Available from: https:\/\/www.who.int\/health-topics\/ageing"},{"key":"3361_CR2","unstructured":"Population projections for India and. states 2011\u20132036 [Internet]. New Delhi: National Commission on Population, Ministry of Health and Family Welfare, Government of India; 2020 [cited 2025 Oct 7]. Available from: https:\/\/main.mohfw.gov.in\/sites\/default\/files\/Population%20Projection%20Report%202011-2036%20-%20upload_compressed_0.pdf"},{"key":"3361_CR3","unstructured":"International Agency for Research on Cancer. Cancer Tomorrow: predictions of the future cancer incidence and mortality burden worldwide up until 2050 [Internet]. Lyon: International Agency for Research on Cancer; [cited 2025 Oct 7]. Available from: https:\/\/gco.iarc.fr\/tomorrow\/en"},{"issue":"8","key":"3361_CR4","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","volume":"38","author":"A Richters","year":"2020","unstructured":"Richters A, Aben KKH, Kiemeney LALM. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38(8):1895\u2013904.","journal-title":"World J Urol"},{"key":"3361_CR5","first-page":"111","volume":"353","author":"ED Crawford","year":"1990","unstructured":"Crawford ED, Natale RB, Burton H. Southwest Oncology Group Study 8710: trial of cystectomy alone versus neo-adjuvant M-VAC and cystectomy in patients with locally advanced bladder cancer (Intergroup Trial 0080). Prog Clin Biol Res. 1990;353:111\u20133.","journal-title":"Prog Clin Biol Res"},{"issue":"17","key":"3361_CR6","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","volume":"18","author":"H von der Maase","year":"2000","unstructured":"von der Maase H, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ, et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol. 2000;18(17):3068\u201377.","journal-title":"J Clin Oncol"},{"issue":"18","key":"3361_CR7","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1200\/JCO.21.02051","volume":"40","author":"C Pfister","year":"2022","unstructured":"Pfister C, Gravis G, Fl\u00e9chon A, Chevreau C, Mahammedi H, Laguerre B, et al. Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial. J Clin Oncol. 2022;40(18):2013\u201322.","journal-title":"J Clin Oncol"},{"issue":"18","key":"3361_CR8","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1200\/JCO.2013.53.2465","volume":"32","author":"ER Plimack","year":"2014","unstructured":"Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, et al. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity. J Clin Oncol. 2014;32(18):1895\u2013901.","journal-title":"J Clin Oncol"},{"issue":"5","key":"3361_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1055\/s-0042-1760317","volume":"45","author":"S Rajappa","year":"2024","unstructured":"Rajappa S, Raja T, Desai C, Joshi A, Dattatreya PS, Agarwal M, et al. Expert Opinion from an Indian Panel via Delphi Consensus: Management of Locally Advanced Unresectable or Metastatic Urothelial Carcinoma. Indian J Med Paediatr Oncol. 2024;45(5):365\u201375.","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"3","key":"3361_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4103\/iju.IJU_540_20","volume":"37","author":"A Chatterjee","year":"2021","unstructured":"Chatterjee A, Bakshi G, Pal M, Kapoor A, Joshi A, Prakash G. Perioperative therapy in muscle invasive bladder cancer. Indian J Urol. 2021;37(3):227\u201334.","journal-title":"Indian J Urol"},{"issue":"16","key":"3361_CR11","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1002\/cncr.26675","volume":"118","author":"C Blick","year":"2012","unstructured":"Blick C, Hall P, Pwint T, Al-Terkait F, Crew J, Powles T, et al. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder. Cancer. 2012;118(16):3920\u20137.","journal-title":"Cancer"},{"key":"3361_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2165\/11591990-000000000-00000","volume":"28","author":"P Crome","year":"2011","unstructured":"Crome P, Lally F, Cherubini A. Exclusion of older people from clinical trials: professional views from nine European countries participating in the PREDICT study. Drugs Aging. 2011;28:667\u201377.","journal-title":"Drugs Aging"},{"issue":"17","key":"3361_CR13","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1200\/JCO.2011.34.8433","volume":"29","author":"MD Galsky","year":"2011","unstructured":"Galsky MD, Hahn NM, Rosenberg J, Sonpavde G, Hutson T, Oh WK, et al. Treatment of patients with metastatic urothelial cancer unfit for Cisplatin-based chemotherapy. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(17):2432\u20138.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3361_CR14","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), Version 5.0 [Internet]. Bethesda (MD): National Cancer Institute; 2017 [cited 2021 Oct 24]. Available from: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf"},{"issue":"18","key":"3361_CR15","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1200\/JCO.2013.52.4785","volume":"32","author":"TK Choueiri","year":"2014","unstructured":"Choueiri TK, Jacobus S, Bellmunt J, Qu A, Appleman LJ, Tretter C, et al. Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates. J Clin Oncol. 2014;32(18):1889\u201394.","journal-title":"J Clin Oncol"},{"issue":"4","key":"3361_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.21926\/obm.geriatr.2104183","volume":"5","author":"C Dumont","year":"2021","unstructured":"Dumont C, Lef\u00e8vre M, Aussedat Q, Reignier PL, Masson-Lecomte A, Xylinas E, et al. Cisplatin-Based Neoadjuvant Chemotherapy for Elderly Patients with Muscle-Invasive Bladder Cancer: Is It Feasible? OBM Geriatr. 2021;5(4):183.","journal-title":"OBM Geriatr"},{"issue":"22","key":"3361_CR17","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","volume":"36","author":"SG Mohile","year":"2018","unstructured":"Mohile SG, Dale W, Somerfield MR, Schonberg MA, Boyd CM, Burhenn PS, et al. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. J Clin Oncol. 2018;36(22):2326\u201347.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3361_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4235\/agmr.22.0062","volume":"26","author":"LM Vaishnav","year":"2022","unstructured":"Vaishnav LM, Joshi SH, Joshi AU, Mehendale AM. The National Programme for Health Care of the Elderly: A Review of its Achievements and Challenges in India. Ann Geriatr Med Res. 2022;26(3):183\u201395.","journal-title":"Ann Geriatr Med Res"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03361-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03361-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03361-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:21:33Z","timestamp":1788924093000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03361-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":18,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["3361"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03361-z","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"<b>Competing Interests<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"248"}}